Startups are working to modernize laboratory research, pre-clinical development, recruitment, and many other aspects of the traditionally time- and resource-intensive clinical trials process.
The pharmaceutical industry has been diving headfirst into digital health, from the formation of digital health-focused corporate venture groups like Merck’s Global Health Innovation Fund to partnerships with AI startups to accelerate drug discovery.
Now, the multibillion-dollar pharma industry is seeing opportunities to bring tech to R&D efforts, from drug discovery to clinical trial recruitment to study publication.
And with good reason. Development of a drug, from discovery through FDA approval, can typically take more than 10 years and cost over $1B.
We used CB Insights data to surface 63 startups changing the traditional pharmaceutical R&D process. These companies range from robotics startups accelerating pre-clinical lab work to platforms enabling virtual clinical trial management. They do not include traditional contract research organizations.
This market map is limited to private, active companies that have raised funding since 2015. While most companies are already being used by clinical research organizations and pharmaceutical corporates alike, some are still early-stage and are intended to show where the trial process is heading.
This market map is not meant to be exhaustive of companies in the space. Categories are not mutually exclusive.
Please click to enlarge.